Production (Stage)
Integrated Biopharma, Inc.
INBP
$0.29
-$0.0135-4.45%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 611.00K | 116.00K | 259.00K | 268.00K | 285.00K |
| Total Depreciation and Amortization | 304.00K | 318.00K | 320.00K | 317.00K | 304.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 258.00K | 125.00K | 253.00K | 139.00K | 142.00K |
| Change in Net Operating Assets | -557.00K | -358.00K | -175.00K | -910.00K | 912.00K |
| Cash from Operations | 616.00K | 201.00K | 657.00K | -186.00K | 1.64M |
| Capital Expenditure | -116.00K | -29.00K | -56.00K | -146.00K | -345.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -116.00K | -29.00K | -56.00K | -146.00K | -345.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | 0.00 | -7.00K | -11.00K | -10.00K |
| Issuance of Common Stock | 0.00 | 18.00K | -- | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 18.00K | -7.00K | -11.00K | -10.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 500.00K | 190.00K | 594.00K | -343.00K | 1.29M |